search
checkpoint immunotherapy
Trends
- 1Checkpoint immunotherapy reshapes immune environment in lymph nodes▼Checkpoint Immunotherapy Reshapes Immune Environment in Lymph Nodes | Newswise
New research indicates that checkpoint immunotherapy does more than attack tumors directly: it reshapes the immune environment within lymph nodes, altering how immune cells behave there. The findings could refine understanding of how cancer immunotherapies work and why some patients respond better than others, drawing attention from oncology researchers and clinicians following advances in immunotherapy.
- 2Menarini and Georgiamune Sign $1.1 Billion Cancer Immunotherapy Deal▼Menarini and Georgiamune Strike $1.1 Billion Licensing Deal to Advance Next-Generation Cancer Immunotherapy
Italy's Menarini Group has struck a licensing agreement worth up to $1.1 billion with US biotech Georgiamune to develop next-generation cancer immunotherapies. The deal gives Menarini rights to advance Georgiamune's pipeline, with payments tied to development and commercial milestones. The partnership highlights growing pharmaceutical interest in novel immunotherapy approaches as companies seek new oncology treatments beyond existing checkpoint inhibitors.